🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Wegovy use among US teens up 50% as obesity crisis worsens reuters.com/business/healt… via Chad Terhune & Robin Respaut

The Public Integrity Section is not filing new cases. Its staff has been reduced from more than 30 attorneys to four. And its role reviewing potential cases against members of Congress has been suspended. By me, Ned Parker Peter Eisler and Andrew Goudsward reuters.com/investigations…

Great coverage by Chad Terhune of Reuters on what's happening with the vaccines advisory committee (ACIP). I preview work we've done on conflict of interest trends in ACIP. USC Price School USC Schaeffer reuters.com/business/healt…

Exclusive: Kennedy's new vaccine adviser was expert witness against Merck vaccine reuters.com/business/healt…

Kennedy's new vaccine adviser was expert witness against Merck vaccine reuters.com/business/healt… Reuters Dan Levine Chad Terhune

For my latest story, we spent more than a year closely following four teens and their families to examine in detail the impact of #obesity treatment with the new GLP-1 drugs #pediatrics #health reuters.com/investigates/s…

Watch this powerful video where teens describe the challenges they face from #obesity and how medical treatment played out for them. Full story @reuters youtu.be/9-NbVS1adwE?fe… #GLP1

My latest story: New data show most patients now stay on Wegovy, Zepbound after a year, reversing prior trends #obesity #GLP1 reuters.com/business/healt…

ICYMI: This is our deep dive into the lives of four teens who are at the forefront of a monumental shift in the treatment of childhood #obesity. Meet Austin, Katie, Leo and Stephanie: reuters.com/investigates/s… @longreads #GLP1 #weightloss

Exclusive: FDA to request Sarepta to stop all shipments of gene therapy Elevidys, source says Bhanvi (She/her) reuters.com/business/healt…

🔊 One teen shares his obesity-journey. Hear how weight-loss drugs are offering life-changing results but with unknown long-term effects. Chad Terhune and @robinrespaut discuss with Christopher Walljasper on this special episode of Reuters World News podcast reut.rs/44HwS8w

🔊 Hear from a parent taking the leap to help her child fight obesity with new medications. Don’t miss this special episode of Reuters World News podcast with Christopher Walljasper, Chad Terhune and @robinrespaut reut.rs/4m47iAm

🔊 Doctors are split on the long-term impact of weight-loss drugs for teens vs. the benefits of slimming down. Learn more on this special episode of Reuters World News podcast with Christopher Walljasper Chad Terhune and @robinrespaut reut.rs/3GVUpcx

Pediatricians are seeing more teens with type2 diabetes and liver disease due to rising rates of obesity. Now, weight-loss drugs could slow them. Listen to this special episode of Reuters World News podcast with Christopher Walljasper, Chad Terhune and @robinrespaut reut.rs/4eVIvMi

Listen to the podcast episode on our story about #Wegovy and the future of childhood #obesity reuters.com/podcasts/wegov…

🔊 On a special episode of Reuters World News, we sit down with a pediatric obesity specialist to understand the role of powerful new weight loss drugs in combating childhood obesity. Listen now with Christopher Walljasper, Chad Terhune and @robinrespaut reut.rs/4m3oTbw

🔊 Young people struggling with weight often face relentless bullying and mental health challenges. New medications offer the possibility of life-changing results but come with an uncertain future. Listen with Christopher Walljasper, Chad Terhune and @robinrespaut reut.rs/4518cqt

🔊 A mother opens up about the freedom, challenges, and costs of long-term medication for her son, who has struggled with obesity for years. Listen on this special episode of Reuters World News podcast with Christopher Walljasper, Chad Terhune and @robinrespaut reut.rs/3GQWBlE

🔊 Is lifelong medication the answer for some teens struggling with obesity? Experts and parents weigh in — listen now on this special episode of the Reuters World News podcast with Christopher Walljasper, Chad Terhune and @robinrespaut reut.rs/44FBbRI

🔊 Families face tough choices when treating childhood obesity — from chronic illness and unknown side effects to high costs and shifting insurance coverage. Hear their perspective with Christopher Walljasper, Chad Terhune and @robinrespaut reut.rs/3IEr7Q5